Author

Mingying Zheng

Observed name: M.-Y. Zheng

Institutions: Bureau of Geology and Mineral Exploration and Development of Guizhou Province, Yangzhou University

Observed institutions: Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangdong Provincial People's Hospital, Bureau of Geology and Mineral Exploration and Development of Guizhou Province, Southern Medical University, Yangzhou University

ORCID: 0000-0001-9013-7956

Observed ORCID: 0000-0001-9013-7956

OpenAlex ID: A5112908489

Effect of pH, temperature and solvent mole ratio on solubility of disodium 5′-guanylate in water+ethanol system

2011 · Rui Zhang, Jian Ma, et al. · Fluid Phase Equilibria · 15

Interactions among heavy metals, bacterial communities, mobile genetic elements, and virulence factor genes in shaping antibiotic resistance gene profiles in soils surrounding a 20-year-old landfill

2025 · Huawei Wei, Anbo You, et al. · Journal of Hazardous Materials · 13

A Bacterial Endophyte Bacillus amyloliquefaciens W10 Enhances the Tomato Resistance Against Tuta absoluta

2025 · Mingshi Qian, Chaoqi Sheng, et al. · Agronomy · 5

Elucidating the role of two types of essential oils in regulating antibiotic resistance in soil

2023 · Huawei Wei, Dong Wu, et al. · Journal of Hazardous Materials · 4

Biomarker-integrated study of single agent targeting molecular alterations of PI3KCA, MET, ALK, ROS1, KRAS, NRAS or BRAF in advanced NSCLC: Phase 2 umbrella trial in China (CTONG1505)

2018 · Q. Zhou, X.-C. Zhang, et al. · Annals of Oncology · 4

WS02.13 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)

2023 · S.-Y.M. Liu, J.-Y. Deng, et al. · Journal of Thoracic Oncology · 1

P2.06-07 PD-L1 Expression Guidance on Sintilimab versus Pembrolizumab in Untreated Advanced NSCLC (CTONG1901)

2023 · S.-Y.M. Liu, J.-Y. Deng, et al. · Journal of Thoracic Oncology

Works count: 7

Citation count: 42

H-index: 4

I10-index: 2